BioCentury
ARTICLE | Clinical News

EC approves Pfizer's Trumenba

August 4, 2017 4:46 PM UTC

In May, the European Commission approved Trumenba meningococcal group B vaccine (recombinant LP2086, PF-5212366) from Pfizer Inc. (NYSE:PFE) to prevent invasive meningococcal disease caused by Neisse...

BCIQ Company Profiles

Pfizer Inc.